{"id":36098,"date":"2022-09-03T16:36:04","date_gmt":"2022-09-03T16:36:04","guid":{"rendered":"https:\/\/haberulus.net\/?p=36098"},"modified":"2022-09-03T16:36:04","modified_gmt":"2022-09-03T16:36:04","slug":"cinde-yeni-covid-19-asisina-acil-kullanim-onayi-verildi","status":"publish","type":"post","link":"https:\/\/haberulus.net\/?p=36098","title":{"rendered":"\u00c7in\u2019de, yeni Covid-19 a\u015f\u0131s\u0131na acil kullan\u0131m onay\u0131 verildi"},"content":{"rendered":"<p><b>\u00c7in, Livzon Pharmacuetical Grup taraf\u0131ndan geli\u015ftiren, yeni yerli \u00fcretim Covid-19 a\u015f\u0131s\u0131n\u0131n acil kullan\u0131m\u0131na izin verdi.<\/b><\/p>\n<p>Ulusal bas\u0131ndaki haberlere g\u00f6re, protein bazl\u0131 a\u015f\u0131n\u0131n hat\u0131rlatma dozu olarak uygulanmas\u0131na onay verildi.<\/p>\n<p>Bu, \u00c7in\u2019de kamuya ait Sinopharm ve Sinovac \u015firketleri taraf\u0131ndan geli\u015ftirilen inaktif Covid-19 a\u015f\u0131lar\u0131 ile birlikte bug\u00fcne dek acil kullan\u0131m\u0131na onay verilen 8. yerli a\u015f\u0131 oldu.<\/p>\n<p><strong>OMICRON\u2019A KAR\u015eI Y\u00dcZDE 47 ETK\u0130L\u0130<\/strong><\/p>\n<p>A\u015f\u0131n\u0131n, sonu\u00e7lar\u0131 \u201cEmerging Microbes &#038; Infections\u201d dergisinde yay\u0131mlanan klinik denemelerinde, hastal\u0131k riskini y\u00fczde 47,8 azaltt\u0131\u011f\u0131 bildirilmi\u015fti. 10 bin ki\u015fi \u00fczerinde yap\u0131lan denemelerde a\u015f\u0131n\u0131n Omicron varyant\u0131na kar\u015f\u0131 ise y\u00fczde 47 etkinlik sa\u011flad\u0131\u011f\u0131 tespit edilmi\u015fti.<\/p>\n<p>Livzon, temmuzda yapt\u0131\u011f\u0131 a\u00e7\u0131klamada, a\u015f\u0131n\u0131n hat\u0131rlatma dozu olarak uyguland\u0131\u011f\u0131nda \u00f6zellikle ya\u015fl\u0131 n\u00fcfus grubunda ba\u015far\u0131l\u0131 oldu\u011funun g\u00f6zlendi\u011fini kaydetmi\u015fti.<\/p>\n<p>Ulusal Sa\u011fl\u0131k Komisyonunun temmuz verilerine g\u00f6re, \u00c7in\u2019de 80 ya\u015f \u00fczeri yakla\u015f\u0131k 35 milyonluk n\u00fcfusun y\u00fczde 62\u2019si hen\u00fcz hat\u0131rlatma dozunu yapt\u0131rm\u0131\u015f de\u011fil.<\/p>\n<p>Ya\u015fl\u0131 n\u00fcfusta a\u015f\u0131lanma oran\u0131n\u0131n istenilen seviyede olmamas\u0131, vir\u00fcs\u00fcn yay\u0131lmas\u0131yla \u00f6l\u00fcmlerin artabilece\u011fi endi\u015fesine yol a\u00e7\u0131yor.<\/p>\n<p>Yurt d\u0131\u015f\u0131nda geli\u015ftirilen Covid-19 a\u015f\u0131lar\u0131n\u0131n hi\u00e7birinin \u00c7in ana karas\u0131nda kullan\u0131m\u0131na hen\u00fcz izin verilmi\u015f de\u011fil.<\/p>\n<p><strong>\u201cSIFIR VAKA\u201d POL\u0130T\u0130KASI<\/strong><\/p>\n<p>\u00c7in\u2019de vaka say\u0131s\u0131 di\u011fer \u00fclkelere k\u0131yasla az olmas\u0131na ra\u011fmen, Pekin, vir\u00fcs\u00fcn yay\u0131lmas\u0131n\u0131 \u00f6nlemeye y\u00f6nelik \u201cs\u0131f\u0131r vaka\u201d stratejini \u0131srarl\u0131 \u015fekilde uygulamaya devam ediyor.<\/p>\n<p>Strateji, karantina, seyahat k\u0131s\u0131tlamalar\u0131, toplu testler, imalat, ticaret ve hizmetler sekt\u00f6r\u00fcndeki i\u015fletmelerin faaliyetlerinin k\u0131s\u0131tlanmas\u0131 gibi kat\u0131 ve geni\u015f \u00f6l\u00e7ekli tedbirleri gerektiriyor.<br \/>Salg\u0131n \u00f6nleme ve kontrol tedbirleri, hayat\u0131n ola\u011fan ak\u0131\u015f\u0131na m\u00fcdahalenin yan\u0131nda ekonomik maliyeti a\u00e7\u0131s\u0131ndan da tart\u0131\u015fmalara yol a\u00e7\u0131yor.<\/p>\n<p>Omicron varyant\u0131n\u0131n bula\u015f\u0131c\u0131l\u0131\u011f\u0131 y\u00fcksek BA.4 ve BA.5 alt varyantlar\u0131n\u0131n yay\u0131lmas\u0131yla son haftalarda artan vaka say\u0131s\u0131, bu hafta i\u00e7inde toplam n\u00fcfuslar\u0131 40 milyona yakla\u015fan, Si\u00e7uan eyaletinin \u00c7\u0131ngdu, Guangdong eyaletinin \u015e\u0131nc\u0131n ve Liaoning eyaletinin Dalian \u015fehirlerinde kapanma ve di\u011fer karantina tedbirlerini yeniden g\u00fcndeme getirmi\u015fti. <strong>AA<\/strong><\/p>\n","protected":false},"excerpt":{"rendered":"<p>\u00c7in, Livzon Pharmacuetical Grup taraf\u0131ndan geli\u015ftiren, yeni yerli \u00fcretim Covid-19 a\u015f\u0131s\u0131n\u0131n acil kullan\u0131m\u0131na izin verdi. Ulusal bas\u0131ndaki &#8230;<\/p>\n","protected":false},"author":1,"featured_media":36099,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[30],"tags":[180,793],"class_list":["post-36098","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-saglik","tag-asi","tag-cin"],"_links":{"self":[{"href":"https:\/\/haberulus.net\/index.php?rest_route=\/wp\/v2\/posts\/36098","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/haberulus.net\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/haberulus.net\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/haberulus.net\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/haberulus.net\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=36098"}],"version-history":[{"count":1,"href":"https:\/\/haberulus.net\/index.php?rest_route=\/wp\/v2\/posts\/36098\/revisions"}],"predecessor-version":[{"id":36100,"href":"https:\/\/haberulus.net\/index.php?rest_route=\/wp\/v2\/posts\/36098\/revisions\/36100"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/haberulus.net\/index.php?rest_route=\/wp\/v2\/media\/36099"}],"wp:attachment":[{"href":"https:\/\/haberulus.net\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=36098"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/haberulus.net\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=36098"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/haberulus.net\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=36098"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}